RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:CRDL will rise like a Phoenix Six months later...their product isn't 'superior', it's the same - there's only one type of pharma produced 100% THC free cbd and everyone in the USA has it now and BioVectra in Canada can do the same with larger q's so this co has no moat at all.
We've been listening to pie-in-the-sky now for...years now and, as said, the market is simply getting tired of it as reflected in the SP and even if these trials turn out, what exactly is the market for it, other than from what comes out of CRDL's mouth? And, if they do have a heart prod., at their pricing prowess, what plan is going to pay for it? And what generic will come riight out with it soon-after?
What's holding it above $2 is beyond anyone's guess and can only be explained as pumpers trading between each other in low volumes trying to save a sinking ship that they have too much $ tied up in that they don't want to lose.
Belongs on the TSV.
AGAIN!!! https://www.youtube.com/watch?v=AIWaJC3_-PE